VH
Valius Health, Inc.
SEC filingBiotechnology · San Francisco, CA
Amount raised$9.7Msold at filing
Total offering$10.2M$500K still open
Investors in the raise6count reported to the SEC
FiledApr 13, 2026first sale Mar 25, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Edward LarkinExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.